DZ2283A1 - Composition de vaccin. - Google Patents

Composition de vaccin.

Info

Publication number: DZ2283A1
Authority: DZ; Algeria
Prior art keywords: vaccine composition; vaccine; composition
Prior art date: 1996-08-02

Application number

DZ970133A

Other languages

English (en)

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-02

Filing date

1997-07-30

Publication date

2002-12-25

1997-07-30 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2002-12-25 Application granted granted Critical

2002-12-25 Publication of DZ2283A1 publication Critical patent/DZ2283A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Immunology (AREA)
Mycology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DZ970133A 1996-08-02 1997-07-30 Composition de vaccin. DZ2283A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9616351.4A GB9616351D0 (en)	1996-08-02	1996-08-02	Vaccine composition

Publications (1)

Publication Number	Publication Date
DZ2283A1 true DZ2283A1 (fr)	2002-12-25

Family

ID=10797980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970133A DZ2283A1 (fr)	1996-08-02	1997-07-30	Composition de vaccin.

Country Status (32)

Country	Link
US (2)	US20020172692A1 (fr)
EP (2)	EP0957933B1 (fr)
JP (1)	JP2000517295A (fr)
KR (1)	KR20000029747A (fr)
CN (1)	CN1241639C (fr)
AP (1)	AP1166A (fr)
AR (1)	AR008799A1 (fr)
AT (1)	ATE394119T1 (fr)
AU (1)	AU706303B2 (fr)
BG (1)	BG63290B1 (fr)
BR (1)	BR9710913A (fr)
CA (1)	CA2262402A1 (fr)
CO (1)	CO4650186A1 (fr)
CZ (1)	CZ290826B6 (fr)
DE (1)	DE69738672D1 (fr)
DZ (1)	DZ2283A1 (fr)
EA (1)	EA002167B1 (fr)
GB (1)	GB9616351D0 (fr)
ID (1)	ID17860A (fr)
IL (1)	IL128318A (fr)
MA (1)	MA24291A1 (fr)
MY (1)	MY116128A (fr)
NO (1)	NO319844B1 (fr)
OA (1)	OA10969A (fr)
PE (1)	PE97298A1 (fr)
PL (1)	PL188741B1 (fr)
SK (1)	SK282438B6 (fr)
TR (1)	TR199900195T2 (fr)
UA (1)	UA68336C2 (fr)
UY (1)	UY24654A1 (fr)
WO (1)	WO1998005355A1 (fr)
ZA (1)	ZA976815B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9915204D0 (en) *	1999-06-29	1999-09-01	Smithkline Beecham Biolog	Vaccine
NZ539509A (en)	2002-10-23	2008-05-30	Glaxosmithkline Biolog Sa	Priming vaccine comprising a polynucleotide encoding at least one first malarial antigen and a boosting vaccine comprising at least one polypeptide comprising at least one second malarial antigen having at least one epitope in common with the first malarial antigen of the priming vaccine
AU2004303647B2 (en) *	2003-12-01	2010-05-27	Meiji Dairies Corporation	Peptide inhibiting angiotensin converting enzyme
GB0513421D0 (en)	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
EP1909830B1 (fr) *	2005-08-02	2011-09-28	Novartis Vaccines and Diagnostics S.r.l.	Reduction des interactions entre adjuvants huileux et antigenes tensioactifs
GB0614254D0 (en) *	2006-07-18	2006-08-30	Smithkline Beecham Biolog	Vaccine
EP2040743B1 (fr) *	2006-07-18	2013-10-02	GlaxoSmithKline Biologicals S.A.	Vaccins contre le paludisme
AU2007293672B2 (en)	2006-09-07	2013-06-27	Glaxosmithkline Biologicals S.A.	Vaccine
CL2008002361A1 (es)	2007-08-13	2009-08-07	Glaxosmithkline Biologicals Sa	Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria.
JP2011507816A (ja) *	2007-12-21	2011-03-10	グラクソスミスクラインバイオロジカルズソシエテアノニム	マラリア用ワクチン
AU2008339969A1 (en)	2007-12-24	2009-07-02	Glaxosmithkline Biologicals S.A.	Vaccines for malaria
US20120015000A1 (en) *	2008-06-30	2012-01-19	David Lanar	Malaria vaccine of self-assembling polypeptide nanoparticles
CA2769996C (fr) *	2009-11-05	2018-06-12	The United States Of America As Represented By The Secretary Of The Na	Antigenes de sporozoites de plasmodium falciparum en phase hepatique
CA2809463C (fr)	2010-09-27	2021-05-25	Crucell Holland B.V.	Regime de vaccination de type amorce rappel heterologue contre la malaria
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
US20130122038A1 (en)	2011-11-14	2013-05-16	The United States Of America As Represented By The Secretary Of The Department	Heterologous prime-boost immunization using measles virus-based vaccines
US9169304B2 (en)	2012-05-01	2015-10-27	Pfenex Inc.	Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN104338129B (zh) *	2013-07-26	2017-05-24	中国科学院上海巴斯德研究所	雷帕霉素作为疫苗佐剂的用途及制备方法
BR112019011286A2 (pt)	2016-12-07	2019-10-15	Glaxosmithkline Biologicals S.A.	métodos para produzir uma composição de lipossoma, para preparar uma composição de vacina e para preparar um kit de vacina.
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
CN111032080A (zh)	2017-05-30	2020-04-17	葛兰素史密丝克莱恩生物有限公司	用于制造佐剂的新型方法
EP3717001A1 (fr)	2017-12-01	2020-10-07	GlaxoSmithKline Biologicals S.A.	Purification de saponine
EP3980044A1 (fr)	2019-06-05	2022-04-13	GlaxoSmithKline Biologicals SA	Purification de saponine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0071705B1 (fr) *	1981-05-21	1989-11-23	The Wellcome Foundation Limited	Antigène protozoaire
ES8800273A1 (es) *	1985-03-28	1987-11-01	Univ New York	Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
GB8819209D0 (en) *	1988-08-12	1988-09-14	Research Corp Ltd	Polypeptide & dna encoding same
GB9012580D0 (en) *	1990-06-06	1990-07-25	Univ Nijmegen	Novel protein
FR2679776A1 (fr) *	1991-07-31	1993-02-05	Pasteur Institut	Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
WO1993010152A1 (fr) *	1991-11-16	1993-05-27	Smithkline Beecham Biologicals S.A.	Proteine hybride entre la proteine cs de plasmodium et l'antigene de surface du virus de l'hepatite b
US6169171B1 (en) *	1992-02-27	2001-01-02	Smithkline Beecham Biologicals (S.A.)	Hybrid protein between CS from plasmodium and HBSAG
UA40597C2 (uk) *	1992-06-25	2001-08-15	Смітклайн Бічем Байолоджікалс С.А.	Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
AUPM368994A0 (en) *	1994-02-04	1994-02-24	Saramane Pty Ltd	Malaria merozoite antigen subunit vaccine
FR2744724B1 (fr) *	1996-02-14	2002-08-02	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) *	1996-02-14	1997-08-14	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

1996
- 1996-08-02 GB GBGB9616351.4A patent/GB9616351D0/en active Pending
1997
- 1997-07-30 DZ DZ970133A patent/DZ2283A1/fr active
- 1997-07-31 AT AT97940062T patent/ATE394119T1/de not_active IP Right Cessation
- 1997-07-31 CN CNB971983607A patent/CN1241639C/zh not_active Expired - Fee Related
- 1997-07-31 AU AU42040/97A patent/AU706303B2/en not_active Ceased
- 1997-07-31 PL PL97331424A patent/PL188741B1/pl not_active IP Right Cessation
- 1997-07-31 EP EP97940062A patent/EP0957933B1/fr not_active Expired - Lifetime
- 1997-07-31 MA MA24749A patent/MA24291A1/fr unknown
- 1997-07-31 CA CA002262402A patent/CA2262402A1/fr not_active Abandoned
- 1997-07-31 EA EA199900069A patent/EA002167B1/ru not_active IP Right Cessation
- 1997-07-31 IL IL12831897A patent/IL128318A/en not_active IP Right Cessation
- 1997-07-31 AP APAP/P/1999/001448A patent/AP1166A/en active
- 1997-07-31 CZ CZ1999292A patent/CZ290826B6/cs not_active IP Right Cessation
- 1997-07-31 EP EP05077131A patent/EP1623720A3/fr not_active Withdrawn
- 1997-07-31 ID IDP972672A patent/ID17860A/id unknown
- 1997-07-31 BR BR9710913A patent/BR9710913A/pt not_active Application Discontinuation
- 1997-07-31 WO PCT/EP1997/004326 patent/WO1998005355A1/fr not_active Ceased
- 1997-07-31 TR TR1999/00195T patent/TR199900195T2/xx unknown
- 1997-07-31 KR KR1019997000855A patent/KR20000029747A/ko not_active Ceased
- 1997-07-31 JP JP10507631A patent/JP2000517295A/ja active Pending
- 1997-07-31 DE DE69738672T patent/DE69738672D1/de not_active Expired - Fee Related
- 1997-07-31 SK SK115-99A patent/SK282438B6/sk unknown
- 1997-07-31 MY MYPI97003495A patent/MY116128A/en unknown
- 1997-07-31 UA UA99010527A patent/UA68336C2/uk unknown
- 1997-07-31 ZA ZA9706815A patent/ZA976815B/xx unknown
- 1997-08-01 AR ARP970103502A patent/AR008799A1/es not_active Application Discontinuation
- 1997-08-01 PE PE1997000672A patent/PE97298A1/es not_active Application Discontinuation
- 1997-08-01 UY UY24654A patent/UY24654A1/es not_active IP Right Cessation
- 1997-08-01 CO CO97044242A patent/CO4650186A1/es unknown
1999
- 1999-02-01 NO NO19990464A patent/NO319844B1/no unknown
- 1999-02-02 OA OA9900022A patent/OA10969A/en unknown
- 1999-02-02 BG BG103141A patent/BG63290B1/bg unknown
2001
- 2001-12-18 US US10/024,860 patent/US20020172692A1/en not_active Abandoned
2006
- 2006-08-11 US US11/463,933 patent/US20060292170A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EA199900069A1 (ru)	1999-10-28
AP1166A (en)	2003-06-30
ZA976815B (en)	1998-05-11
CO4650186A1 (es)	1998-09-03
KR20000029747A (ko)	2000-05-25
NO319844B1 (no)	2005-09-19
BG103141A (en)	1999-08-31
EA002167B1 (ru)	2002-02-28
GB9616351D0 (en)	1996-09-11
AP9901448A0 (en)	1999-03-31
DE69738672D1 (de)	2008-06-19
MY116128A (en)	2003-11-28
CN1241639C (zh)	2006-02-15
WO1998005355A1 (fr)	1998-02-12
EP0957933A1 (fr)	1999-11-24
IL128318A (en)	2002-04-21
MA24291A1 (fr)	1998-04-01
NO990464D0 (no)	1999-02-01
EP1623720A2 (fr)	2006-02-08
CZ29299A3 (cs)	1999-06-16
CA2262402A1 (fr)	1998-02-12
BR9710913A (pt)	1999-08-17
SK11599A3 (en)	2000-03-13
SK282438B6 (sk)	2002-02-05
JP2000517295A (ja)	2000-12-26
OA10969A (en)	2003-03-04
IL128318A0 (en)	2000-01-31
EP1623720A3 (fr)	2006-02-22
PE97298A1 (es)	1999-02-14
PL331424A1 (en)	1999-07-19
ID17860A (id)	1998-01-29
BG63290B1 (bg)	2001-09-28
CZ290826B6 (cs)	2002-10-16
TR199900195T2 (xx)	1999-04-21
US20060292170A1 (en)	2006-12-28
ATE394119T1 (de)	2008-05-15
US20020172692A1 (en)	2002-11-21
AR008799A1 (es)	2000-02-23
CN1231613A (zh)	1999-10-13
AU706303B2 (en)	1999-06-10
NO990464L (no)	1999-02-01
UA68336C2 (en)	2004-08-16
UY24654A1 (es)	2001-08-27
EP0957933B1 (fr)	2008-05-07
PL188741B1 (pl)	2005-04-29
AU4204097A (en)	1998-02-25

Publication	Publication Date	Title
DZ2283A1 (fr)	2002-12-25	Composition de vaccin.
DZ2026A1 (fr)	2002-07-21	Compositions vaccinantes.
DZ2055A1 (fr)	2002-10-20	Compositions vaccinantes.
NO20004758D0 (no)	2000-09-22	Vaksinesammensetning
BR9711853A (pt)	1999-08-24	Vacinas
NO20003302D0 (no)	2000-06-23	Vaksine
DZ2462A1 (fr)	2003-01-18	Vaccin antigrippal.
DZ1763A1 (fr)	2002-02-17	Composition vaccinantes.
IS1903B (is)	2003-11-20	2-methýl-thíenó-bensódíasepín, samsetning til inntöku
DE69933200D1 (de)	2006-10-26	Kombinierte impfstoffzusammensetzungen
NL1006622A1 (nl)	1998-02-05	Orthodontische inrichtingen.
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
DE69708120D1 (de)	2001-12-13	Laser-absorbierende, lichtbleichbare zusammensetzungen
EP1083926A4 (fr)	2006-01-18	Vaccin
FI991302A7 (fi)	1999-06-08	Parannetut farmaseuttiset koostumukset
FI972054L (fi)	1997-05-14	Immunogeenisiä koostumuksia
EP0967993A4 (fr)	2001-04-18	Vaccin anti-cocaine
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
NO20005599D0 (no)	2000-11-06	Vaksine
ID18698A (id)	1998-04-30	Komposisi farmasi
FR2715304B1 (fr)	1996-04-26	Vaccin anti-allergique.
FI961364L (fi)	1997-09-26	Lääkeainekoostumus
ITMI962628A0 (it)	1996-12-16	Composizione farmaceutica
ZA984696B (en)	1999-01-04	Vaccine compositions V.
NL300165I2 (nl)	2005-07-01	Babesiavaccin.